Skip to main content
. 2016 Mar;356(3):673–680. doi: 10.1124/jpet.115.230144

Fig. 3.

Fig. 3.

Neither A1AR nor A3AR is required for the AR-mediated vasorelaxation in PAs. (A) CRC to NECA, CCPA and Cl-IBMECA in A2A/A2BAR DKO mice. (B) CRC to CCPA in A2A/A2BAR DKO mice in the presence of vehicle or the A1AR antagonist DPCPX (0.1 μM) and the A3AR antagonist MRS1523 (1 μM). (C) CRC to Cl-IBMECA in A2A/A2BAR DKO mice in the presence of vehicle or DPCPX and MRS1523. Data are represented as mean ± S.E.M. (N = 5–8). *P < 0.05 versus NECA.